-
1
-
-
0031458028
-
Incidence, population, and survival of cystic fibrosis in the UK 1968-95
-
1 Dodge JA, Morrison S, Lewis PA, et al. Incidence, population, and survival of cystic fibrosis in the UK 1968-95. Arch Dis Child 1997; 77:493-496
-
(1997)
Arch Dis Child
, vol.77
, pp. 493-496
-
-
Dodge, J.A.1
Morrison, S.2
Lewis, P.A.3
-
2
-
-
0018743611
-
Improved survival of patients with cystic fibrosis
-
2 Phelan P, Allan J, Landau L, et al. Improved survival of patients with cystic fibrosis. Med J Aust 1979; 1:261-263
-
(1979)
Med J Aust
, vol.1
, pp. 261-263
-
-
Phelan, P.1
Allan, J.2
Landau, L.3
-
3
-
-
0029924585
-
Determinants of mortality from cystic fibrosis in Canada, 1970-1989
-
3 Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996; 143: 1007-1017
-
(1996)
Am J Epidemiol
, vol.143
, pp. 1007-1017
-
-
Corey, M.1
Farewell, V.2
-
4
-
-
0029049405
-
Incidence and mortality rates of cystic fibrosis in Japan, 1969-1992
-
4 Imaizumi Y. Incidence and mortality rates of cystic fibrosis in Japan, 1969-1992. Am J Med Genet 1995; 58:161-168
-
(1995)
Am J Med Genet
, vol.58
, pp. 161-168
-
-
Imaizumi, Y.1
-
5
-
-
0027395872
-
The changing epidemiology of cystic fibrosis
-
5 FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122:1-9
-
(1993)
J Pediatr
, vol.122
, pp. 1-9
-
-
FitzSimmons, S.C.1
-
6
-
-
0024590336
-
Effects of social class, sex, and region of residence on age at death from cystic fibrosis
-
6 Britton JR. Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ 1989; 298:483-487
-
(1989)
BMJ
, vol.298
, pp. 483-487
-
-
Britton, J.R.1
-
8
-
-
0029016495
-
Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection
-
8 Demko C, Byard P, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995; 48:1041-1049
-
(1995)
J Clin Epidemiol
, vol.48
, pp. 1041-1049
-
-
Demko, C.1
Byard, P.2
Davis, P.B.3
-
9
-
-
0030916094
-
Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis
-
9 Curtis JR, Burke W, Kassner AW, et al. Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis. Am J Crit Care 1997; 155:1921-1924
-
(1997)
Am J Crit Care
, vol.155
, pp. 1921-1924
-
-
Curtis, J.R.1
Burke, W.2
Kassner, A.W.3
-
10
-
-
0032513942
-
Clinical outcome in relation to care in centers specialising in cystic fibrosis: Cross sectional study
-
10 Mahadeva R, Webb K, Westerbeek RC, et al. Clinical outcome in relation to care in centers specialising in cystic fibrosis: cross sectional study. BMJ 1998; 316:1771-1775
-
(1998)
BMJ
, vol.316
, pp. 1771-1775
-
-
Mahadeva, R.1
Webb, K.2
Westerbeek, R.C.3
-
11
-
-
0028297909
-
Hospital care for adults with cystic fibrosis: An overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire
-
11 Walters S, Britton JR, Hudson ME. Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire. Thorax 1994; 49:300-306
-
(1994)
Thorax
, vol.49
, pp. 300-306
-
-
Walters, S.1
Britton, J.R.2
Hudson, M.E.3
-
12
-
-
0029379726
-
Complete map of cystic fibrosis ΔF508 frequencies in western Europe and correlation between mutation frequencies and incidence of disease
-
12 Lucotte G, Hazout S, De Braekeleer M. Complete map of cystic fibrosis ΔF508 frequencies in western Europe and correlation between mutation frequencies and incidence of disease. Hum Biol 1995; 67:797-803
-
(1995)
Hum Biol
, vol.67
, pp. 797-803
-
-
Lucotte, G.1
Hazout, S.2
De Braekeleer, M.3
-
13
-
-
0026019534
-
Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation
-
13 Johansen HK, Nir M, Hoiby N, et al. Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet 1991; 337:631-634
-
(1991)
Lancet
, vol.337
, pp. 631-634
-
-
Johansen, H.K.1
Nir, M.2
Hoiby, N.3
|